RICCIO, FLAVIA
 Distribuzione geografica
Continente #
EU - Europa 103
AS - Asia 74
NA - Nord America 55
SA - Sud America 10
AF - Africa 1
Totale 243
Nazione #
RU - Federazione Russa 82
US - Stati Uniti d'America 52
SG - Singapore 22
CN - Cina 19
HK - Hong Kong 10
VN - Vietnam 10
IE - Irlanda 9
BR - Brasile 7
IT - Italia 5
KR - Corea 5
FI - Finlandia 3
IN - India 3
CA - Canada 2
DE - Germania 2
FR - Francia 2
JP - Giappone 2
AR - Argentina 1
CL - Cile 1
ID - Indonesia 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 243
Città #
Moscow 31
San Jose 11
Hong Kong 10
Dublin 9
Singapore 9
Chandler 8
Santa Clara 7
Council Bluffs 5
Hefei 5
Seoul 5
Ashburn 4
New York 4
Beijing 3
Hanoi 3
Naples 3
Bengaluru 2
Ho Chi Minh City 2
Lappeenranta 2
Nuremberg 2
Pindamonhangaba 2
Bangkok 1
Boardman 1
Boston 1
Da Nang 1
Dong Xoai 1
Haiphong 1
Helsinki 1
Jakarta 1
Jardim Cacique 1
Jinan 1
Lima region 1
Longchamps 1
Los Angeles 1
Montreal 1
Mumbai 1
Orem 1
Paris 1
Propriá 1
Rio das Antas 1
Santiago 1
Settat 1
São João da Barra 1
São Paulo 1
Tashkent 1
Thanh Hóa 1
Tokyo 1
Totale 153
Nome #
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 125
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 86
Tofacitinib attenuates IL-6-mediated endothelial tissue factor induction in vitro without affecting platelet aggregation in vivo: mechanistic insights into cardiovascular risk in rheumatoid arthritis 18
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 8
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 6
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 5
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study 4
Totale 252
Categoria #
all - tutte 790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 1 3 4 0 1 8 0 1 0
2023/20248 0 0 1 1 1 3 0 0 0 0 0 2
2024/202535 0 2 0 1 5 7 6 4 3 4 2 1
2025/2026191 7 15 13 5 12 72 14 29 12 12 0 0
Totale 252